Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 1
1(25.0%)
Phase 4
1(25.0%)
4Total
N/A(2)
Phase 1(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04840329Not ApplicableCompleted

Endocation: Trial of an Endometriosis Education Program

Role: collaborator

NCT04652622Not ApplicableCompleted

Use of a Novel Digital Therapeutic Intervention for the Management of Delirium in the Acute Care Environment

Role: collaborator

NCT04555343Phase 1Completed

Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention

Role: collaborator

NCT04796402Phase 4Unknown

A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19

Role: collaborator

All 4 trials loaded